EUVIMEDEUVIMED entdecken
Crossref

Novel inhibitors of oncogenic Wnt/TCF-4/β-catenin signaling pathway: Design, synthesis, molecular docking studies and apoptosis inducing activity of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4-thiadiazolopyrimido-indole hybrids

Mai A E Mourad, Ahmed A E Mourad, Ayman Abo Elmaaty, Amal Hofni, Ahmed E Khodir, Esam M Aboubakr, Wagdy M Eldehna, Ahmed A Al-Karmalawy

Bioorganic Chemistry · 2025

DOI: 10.1016/j.bioorg.2025.108285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2025. Verfasst von Mai A E Mourad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Chemistry Department, Faculty of Pharmacy, Port-Said University, Port-Said 42511, Egypt; Medicinal Chemistry Department, Pharmacology and T…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Apoptosis, Antineoplastic Agents, beta Catenin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wnt pathway is vital for survival of cancer-initiating cells. β-catenin plays a crucial role in Wnt pathway through interaction with TCF-4 to transcribe oncogenes. β-catenin activation suppresses immune cell infiltration into cancer cells and promotes resistance to chemotherapeutic drugs. In order to target Wnt/TCF-4/β-catenin pathway, a novel series of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4 thiadiazolopyrimido-indole hybrids were designed, synthesized and evaluated for their β-catenin/TCF-4 inhibitory and apoptotic inducing activities. Cytotoxicity of the synthesized hybrids was evaluated against HCT-116, A549 and HepG2 cell lines. Of the synthesized hybrids, 6a, 8b and 12b hybrids elicited superior cytotoxic activity compared to quercetin against the tested cell lines. These hybrids were able to significantly suppress β-catenin and its down-stream signaling target TCF-4 in a dose-dependent manner in HCT-116 cell line. They up-regulated p53, caspase-3, caspase-8, caspase-9 levels and Bax protein expression as well as down-regulated Bcl-2 protein expression. They successfully arrested cell cycle in pre-G1 phase and G0/G1 phase. The synthesized hybrids achieved efficient binding pattern in molecular docking study and have acceptable drug likeness characters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationApoptosisAntineoplastic Agentsbeta CateninDrug DesignDrug Screening Assays, AntitumorHumansStructure-Activity RelationshipMolecular StructureCell ProliferationDose-Response Relationship, DrugIndolesWnt Signaling PathwayTranscription Factor 4Cell Line, Tumor

Stichwörter der Autor:innen

ApoptosisIndolePyrimidineTCF-4/β-cateninWnt pathway

Substanzen

Antineoplastic Agentsbeta CateninIndolesTranscription Factor 4TCF4 protein, human

Autor:innen und Institutionen

  • Medicinal Chemistry Department, Faculty of Pharmacy, Port-Said University, Port-Said 42511, Egypt; Medicinal Chemistry Department, Pharmacology and Toxicology Department, Faculty of Pharmacy, East Port-Said National Uni…
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Port-Said University, Port-Said 42511, Egypt; Medicinal Chemistry Department, Pharmacology and Toxicology Department, Faculty of Pharmacy, East Port-Said Nati…
  • Medicinal Chemistry Department, Faculty of Pharmacy, Port-Said University, Port-Said 42511, Egypt. Electronic address: ayman.mohamed@pharm.psu.edu.eg.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt. Electronic address: amal.gaber@svu.edu.eg.
  • Department of Pharmacology, Faculty of Pharmacy, Horus University, New Damietta 34518, Egypt. Electronic address: akhodir@horus.edu.eg.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, South Valley University, Qena 83523, Egypt. Electronic address: esam_pharma@svu.edu.eg.

Zitieren

APA

Mourad, M. A. E., Mourad, A. A. E., Elmaaty, A. A., Hofni, A., Khodir, A. E., Aboubakr, E. M., Eldehna, W. M., & Al-Karmalawy, A. A. (2025). Novel inhibitors of oncogenic Wnt/TCF-4/β-catenin signaling pathway: Design, synthesis, molecular docking studies and apoptosis inducing activity of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4-thiadiazolopyrimido-indole hybrids. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.108285

Vancouver

Mourad MAE, Mourad AAE, Elmaaty AA, Hofni A, Khodir AE, Aboubakr EM, et al. Novel inhibitors of oncogenic Wnt/TCF-4/β-catenin signaling pathway: Design, synthesis, molecular docking studies and apoptosis inducing activity of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4-thiadiazolopyrimido-indole hybrids. Bioorganic Chemistry. 2025. doi:10.1016/j.bioorg.2025.108285

BibTeX
@article{Mourad2025,
  author = {Mourad, Mai A E and Mourad, Ahmed A E and Elmaaty, Ayman Abo and Hofni, Amal and Khodir, Ahmed E and Aboubakr, Esam M and Eldehna, Wagdy M and Al-Karmalawy, Ahmed A},
  title = {Novel inhibitors of oncogenic Wnt/TCF-4/β-catenin signaling pathway: Design, synthesis, molecular docking studies and apoptosis inducing activity of pyrimidothiazino-, dihydropyrimidotriazepino- and 1,3,4-thiadiazolopyrimido-indole hybrids},
  journal = {Bioorganic Chemistry},
  year = {2025},
  doi = {10.1016/j.bioorg.2025.108285}
}
Kostenlos starten →